Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Hornstein

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|September 15, 2016
State of the ART: Assisted Reproductive Technologies in the United StatesMark D Hornstein
Reproductive Sciences (Thousand Oaks, Calif.)|September 10, 2016
Lifestyle and IVF OutcomesMark D Hornstein
Fertility and Sterility|April 15, 2018
Is insurance coverage for in vitro fertilization a good thing?Mark D Hornstein
The New England Journal of Medicine|July 6, 2017
An Oral GnRH Antagonist for Endometriosis - A New Drug for an Old DiseaseMark D Hornstein
Fertility and Sterility|July 10, 2003
To pay or not to payTarun Jain, Mark D Hornstein
Fertility and Sterility|July 13, 2005
Disparities in access to infertility services in a state with mandated insurance coverageTarun Jain, Mark D Hornstein
Obstetrics and Gynecology|April 30, 2002
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-upEric S Surrey, Mark D Hornstein
Fertility and Sterility|October 15, 2003
Is intracytoplasmic sperm injection safe?Matthew G Retzloff, Mark D Hornstein
Current Opinion in Obstetrics & Gynecology|June 1, 2006
Is there a role for preparatory cycle in ovum donation recipients?Sunny H Jun, Mark D Hornstein
Fertility and Sterility|October 22, 2008
Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine modelOfer Fainaru, Mark D Hornstein, Judah Folkman
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Reproductive Sciences (Thousand Oaks, Calif.)|September 15, 2016
State of the ART: Assisted Reproductive Technologies in the United StatesMark D Hornstein
Reproductive Sciences (Thousand Oaks, Calif.)|September 10, 2016
Lifestyle and IVF OutcomesMark D Hornstein
Fertility and Sterility|April 15, 2018
Is insurance coverage for in vitro fertilization a good thing?Mark D Hornstein
The New England Journal of Medicine|July 6, 2017
An Oral GnRH Antagonist for Endometriosis - A New Drug for an Old DiseaseMark D Hornstein
Fertility and Sterility|July 10, 2003
To pay or not to payTarun Jain, Mark D Hornstein
Fertility and Sterility|July 13, 2005
Disparities in access to infertility services in a state with mandated insurance coverageTarun Jain, Mark D Hornstein
Obstetrics and Gynecology|April 30, 2002
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-upEric S Surrey, Mark D Hornstein
Fertility and Sterility|October 15, 2003
Is intracytoplasmic sperm injection safe?Matthew G Retzloff, Mark D Hornstein
Current Opinion in Obstetrics & Gynecology|June 1, 2006
Is there a role for preparatory cycle in ovum donation recipients?Sunny H Jun, Mark D Hornstein
Fertility and Sterility|October 22, 2008
Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine modelOfer Fainaru, Mark D Hornstein, Judah Folkman
Pageof 9